Reduced tumorigenicity of rodent tumour cells and tumour explants following infection with wild type and mutant herpes simplex virus, bovine mammillitis virus and encephalomyocarditis virus.
The tumorigenicity of neoplastic hamster and mouse cell lines and tumour explants was reduced by infection with herpes simplex virus (HSV-1), a thymidine-kinaseless mutant of herpes simplex virus, namely 'MDK', encephalomyocarditis virus (EMC) and bovine mammillitis virus (BMV). There was an approximate relationship between duration of virus infection in vitro and reduction in incidence and/or rate of tumour development. The rate of tumour development was also reduced by 'site inoculation' of virus (HSV-1) at various time intervals following inoculation of tumorigenic BHK 21 cells indicating that virus was capable of reducing the rate of tumour development in a situation where the neoplastic cells were already transplanted into the susceptible host species. It is suggested that the therapeutic role of wild type, mutant or recombinant viruses merits further exploration towards prevention and treatment of human cancer.
Skinner
G R
GR
Department of Medical Microbiology, Medical School, University of Birmingham, UK.
Cowan
M
M
Davies
J
J
Brookes
K
K
Billstrom
M
M
Buchan
A
A
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D004686:Encephalomyocarditis virus; D004769:Enterovirus Infections / Q000276:immunology*; D006561:Herpes Simplex / Q000276:immunology*; D006566:Herpesviridae Infections / Q000276:immunology*; D001911:Herpesvirus 2, Bovine; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D013997:Time Factors; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000473:pathology*